Stem-cell research is blooming in IsraelApr. 16, 2013
At a massive scientific parley next week, 18 Israeli companies and several more from around the world will meet to discuss stem cells, cell therapy, and regenerative medicine in both industry and academia.
Use of human cells to treat disease has expanded dramatically over the past decade, leading to the development of a new field: cell therapy — or, in professional terms, regenerative medicine. It involves introducing cells into body tissue to treat disease.
Over the past few years, the knowledge accumulated in the field has begun to leave the laboratories of academia for the commercial world, the development of innovative treatments in hospitals and even the production of off-the-shelf products. In Israel, 18 companies — an unprecedentedly large proportion in relation to the country’s population — develop or market cell-based treatment products. Three of them develop therapies from stem cells produced from fetal cells. All of these will be on hand at the Israstem Conference next week (April 22 and 23) at the Kfar Maccabiah Convention and Event Center in Ramat Gan.
For the full Haaretz story click here (requires registration).
For a story about Israstem Conference click here (Hebrew).